DKNG vs. IBB
DKNG (DraftKings Inc.) is a stock, while IBB (iShares Nasdaq Biotechnology ETF) is Health & Biotech Equities fund tracking the NASDAQ Biotechnology Index. Over the past 5 years, DKNG returned -12.80%/yr vs 2.57%/yr for IBB. At a 0.40 correlation, their price movements are largely independent.
Performance
DKNG vs. IBB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DKNG achieves a -26.38% return, which is significantly lower than IBB's 1.65% return.
DKNG
- 1D
- 1.04%
- 1M
- 4.96%
- YTD
- -26.38%
- 6M
- -27.91%
- 1Y
- -27.18%
- 3Y*
- 0.09%
- 5Y*
- -12.80%
- 10Y*
- —
IBB
- 1D
- 2.35%
- 1M
- 0.64%
- YTD
- 1.65%
- 6M
- -0.21%
- 1Y
- 37.34%
- 3Y*
- 10.11%
- 5Y*
- 2.57%
- 10Y*
- 6.32%
DKNG vs. IBB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
DKNG DraftKings Inc. | -26.38% | -7.37% | 5.53% | 209.48% | -58.54% | -41.00% | 140.62% |
IBB iShares Nasdaq Biotechnology ETF | 1.65% | 27.98% | -2.41% | 3.76% | -13.69% | 0.95% | 20.29% |
Correlation
The correlation between DKNG and IBB is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.27 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.42 |
Correlation (All Time) Calculated using the full available price history since Apr 27, 2020 | 0.40 |
Over the past year, the correlation between DKNG and IBB has dropped to 0.12 - well below their long-term average of 0.40, suggesting their price drivers have been diverging.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DKNG vs. IBB — Risk / Return Rank
DKNG
IBB
DKNG vs. IBB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for DraftKings Inc. (DKNG) and iShares Nasdaq Biotechnology ETF (IBB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| DKNG | IBB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.46 | ||
| Sortino ratioReturn per unit of downside risk | -3.24 | ||
| Omega ratioGain probability vs. loss probability | 0.93 | 1.32 | -0.39 |
| Calmar ratioReturn relative to maximum drawdown | -0.48 | 3.89 | -4.37 |
| Martin ratioReturn relative to average drawdown | -0.78 | 12.34 | -13.12 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| DKNG | IBB | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.58 | 1.88 | -2.46 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.21 | 0.12 | -0.33 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.27 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.07 | 0.26 | -0.19 |
Drawdowns
DKNG vs. IBB - Drawdown Comparison
The maximum DKNG drawdown since its inception was -85.73%, which is greater than IBB's maximum drawdown of -62.85%. Use the drawdown chart below to compare losses from any high point for DKNG and IBB.
Loading charts...
Drawdown Indicators
| DKNG | IBB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -85.73% | -62.85% | -22.88% |
Max Drawdown (1Y)Largest decline over 1 year | -57.04% | -9.63% | -47.41% |
Max Drawdown (3Y)Largest decline over 3 years | -61.26% | -24.85% | -36.41% |
Max Drawdown (5Y)Largest decline over 5 years | -83.87% | -39.82% | -44.05% |
Max Drawdown (10Y)Largest decline over 10 years | — | -39.82% | — |
Current DrawdownCurrent decline from peak | -64.75% | -3.43% | -61.32% |
Average DrawdownAverage peak-to-trough decline | -48.92% | -21.18% | -27.74% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 34.80% | 3.04% | +31.76% |
Volatility
DKNG vs. IBB - Volatility Comparison
DraftKings Inc. (DKNG) has a higher volatility of 14.41% compared to iShares Nasdaq Biotechnology ETF (IBB) at 7.26%. This indicates that DKNG's price experiences larger fluctuations and is considered to be riskier than IBB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DKNG | IBB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.41% | 7.26% | +7.15% |
Volatility (6M)Calculated over the trailing 6-month period | 35.21% | 15.55% | +19.66% |
Volatility (1Y)Calculated over the trailing 1-year period | 46.99% | 19.99% | +27.00% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 61.13% | 22.01% | +39.12% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 63.21% | 23.23% | +39.98% |
Dividends
DKNG vs. IBB - Dividend Comparison
DKNG has not paid dividends to shareholders, while IBB's dividend yield for the trailing twelve months is around 0.23%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DKNG DraftKings Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
IBB iShares Nasdaq Biotechnology ETF | 0.23% | 0.23% | 0.29% | 0.26% | 0.31% | 0.21% | 0.21% | 0.33% | 0.20% | 0.30% | 0.19% | 0.03% |
Frequently Asked Questions
DKNG and IBB have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DKNG has higher volatility (14.41%) compared to IBB (7.26%). In terms of maximum drawdown, DKNG dropped -85.73% vs IBB's -62.85%.
IBB currently has the higher Sharpe Ratio (1.88 vs -0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DKNG and IBB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer